Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound (TcMRgFUS) of Neurological Disorders:
Sponsor:
InSightec
Brief Summary:
A global post approval study to collect safety and effectiveness data related to ExAblate
Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson’s Movement
Disorders, or Neuropathic Pain within the thalamus and/or pallidum.
Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson’s Movement
Disorders, or Neuropathic Pain within the thalamus and/or pallidum.
Criteria
Inclusion Criteria:
– Meets labeling indication for use per information for prescribers
– Target is accessible by Focused Ultrasound per treatment planning parameters
Exclusion Criteria:
– Do not agree to participate or who are unlikely to participate over an extended period
of time
Locations
- Stanford University, Stanford, California, United States, 94305
